Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Naus

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Sexually Transmitted Infections|May 1, 2008
Intention of parents to have male children vaccinated with the human papillomavirus vaccineG S Ogilvie, V P Remple, F Marra, et al.
Scandinavian Journal of Primary Health Care|February 4, 2010
Reasons for ordering laboratory tests and relationship with frequency of abnormal resultsPaul H H Houben, Ron A G Winkens, Trudy van der Weijden, et al.
Vaccine|January 10, 2024
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network studyM P Muller, C Navarro, S E Wilson, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 6, 2004
National eligible, due, and overdue guidelines for immunization registries: draft recommendations from the Canadian Immunization Registry Network, Data Standards Task GroupN Boulianne, Y A Hemon, T Mawhinney, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|September 10, 2003
Human rabies, British Columbia-January 2003R Parker, D McKay, C Hawes, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|June 26, 2003
Assessment of in-flight transmission of SARS--results of contact tracing, CanadaJ Flint, S Burton, J F Macey, et al.
Vaccine|September 6, 2023
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysisA Phillips, Y Jiang, D Walsh, et al.
Vaccine|February 13, 2024
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individualsK Faksova, D Walsh, Y Jiang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Sexually Transmitted Infections|May 1, 2008
Intention of parents to have male children vaccinated with the human papillomavirus vaccineG S Ogilvie, V P Remple, F Marra, et al.
Scandinavian Journal of Primary Health Care|February 4, 2010
Reasons for ordering laboratory tests and relationship with frequency of abnormal resultsPaul H H Houben, Ron A G Winkens, Trudy van der Weijden, et al.
Vaccine|January 10, 2024
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network studyM P Muller, C Navarro, S E Wilson, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 6, 2004
National eligible, due, and overdue guidelines for immunization registries: draft recommendations from the Canadian Immunization Registry Network, Data Standards Task GroupN Boulianne, Y A Hemon, T Mawhinney, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|September 10, 2003
Human rabies, British Columbia-January 2003R Parker, D McKay, C Hawes, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|June 26, 2003
Assessment of in-flight transmission of SARS--results of contact tracing, CanadaJ Flint, S Burton, J F Macey, et al.
Vaccine|September 6, 2023
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysisA Phillips, Y Jiang, D Walsh, et al.
Vaccine|February 13, 2024
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individualsK Faksova, D Walsh, Y Jiang, et al.
Pageof 4